Symbol="PTGX"
AssetType="Common Stock"
Name="Protagonist Therapeutics Inc"
Description="Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California."
CIK="1377121"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1082622000"
EBITDA="-146183008"
PERatio="None"
PEGRatio="0"
BookValue="5.12"
DividendPerShare="0"
DividendYield="0"
EPS="-2.75"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.292"
ReturnOnEquityTTM="-0.49"
RevenueTTM="0"
GrossProfitTTM="26581000"
DilutedEPSTTM="-2.75"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="39.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="13.27"
PriceToBookRatio="1.925"
EVToRevenue="5.84"
EVToEBITDA="-1.604"
Beta="1.887"
num_52WeekHigh="30.1"
num_52WeekLow="7.24"
num_50DayMovingAverage="23.63"
num_200DayMovingAverage="17.9"
SharesOutstanding="57251000"
DividendDate="None"
ExDividendDate="None"
symbol="PTGX"
open="18.68"
high="19.27"
low="18.67"
price="18.91"
volume="525697.00"
latest_trading_day="2023-08-11"
previous_close="18.80"
change="0.11"
change_percent="0.5851%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="29"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="71"
Volume_recent_avg="1105666"
Change_recent_avg="-0.06"
Delta_recent_avg="1.23"
Variance_recent_avg="0.62"
Change_ratio_recent_avg="-0.35"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="71"
Aroon_momentum_negative="29"
image_negative_thumbnail_id_1="1091"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_negative_thumbnail_id_2="1105"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0138.jpeg"
image_neutral_thumbnail_id_1="432"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="535"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_positive_thumbnail_id_1="622"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0086.jpeg"
image_positive_thumbnail_id_2="958"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0120.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
